The immune system is receiving increasing attention for interstitial lung diseases, as knowledge on its role in fibrosis development and response to therapies is expanding. Uncontrolled immune responses and unbalanced injury-inflammation-repair processes drive the initiation and progression of idiopathic pulmonary fibrosis. The regulatory immune system plays important roles in controlling pathogenic immune responses, regulating inflammation and modulating the transition of inflammation to fibrosis. This review aims to summarize and critically discuss the current knowledge on the potential role of regulatory immune cells, including mesenchymal stromal/stem cells, regulatory T cells, regulatory B cells, macrophages, dendritic cells and myeloid-derived suppressor cells in idiopathic pulmonary fibrosis. Furthermore, we review the emerging role of regulatory immune cells in anti-fibrotic therapy and lung transplantation. A comprehensive understanding of immune regulation could pave the way towards new therapeutic or preventive approaches in idiopathic pulmonary fibrosis.
- van Geffen, C.
- Deißler, A.
- Quante, M.
- Renz, H.
- Hartl, D.
- Kolahian, S.
Keywords
- idiopathic pulmonary fibrosis
- macrophages
- mesenchymal stem/stromal cells
- myeloid-derived suppressor cells
- pharmacotherapy
- regulatory B cells
- regulatory T cells
- transplantation
- the research was conducted in the absence of any commercial or financial
- relationships that could be construed as a potential conflict of interest.
